User login
In women with hypertension and no history of cardiovascular disease (CVD), a regimen of a diuretic plus either a beta-blocker or angiotensin-converting enzyme (ACE) inhibitor reduces the risk of CVD mortality compared with a diuretic plus calcium channel blocker. The evidence continues to mount that calcium channel blockers should be the agent of last resort in the treatment of most patients with hypertension. (LOE=2b–)
In women with hypertension and no history of cardiovascular disease (CVD), a regimen of a diuretic plus either a beta-blocker or angiotensin-converting enzyme (ACE) inhibitor reduces the risk of CVD mortality compared with a diuretic plus calcium channel blocker. The evidence continues to mount that calcium channel blockers should be the agent of last resort in the treatment of most patients with hypertension. (LOE=2b–)
In women with hypertension and no history of cardiovascular disease (CVD), a regimen of a diuretic plus either a beta-blocker or angiotensin-converting enzyme (ACE) inhibitor reduces the risk of CVD mortality compared with a diuretic plus calcium channel blocker. The evidence continues to mount that calcium channel blockers should be the agent of last resort in the treatment of most patients with hypertension. (LOE=2b–)